Search results
Results from the WOW.Com Content Network
The United States Environmental Protection Agency (EPA) maintains and approves test methods, which are approved procedures for measuring the presence and concentration of physical, chemical and biological contaminants; evaluating properties, such as toxic properties, of chemical substances; or measuring the effects of substances under various conditions.
Blood glucose monitoring is the use of a glucose meter for testing the concentration of glucose in the blood ().Particularly important in diabetes management, a blood glucose test is typically performed by piercing the skin (typically, via fingerstick) to draw blood, then applying the blood to a chemically active disposable 'test-strip'.
The EPA's Science Advisory Board also pushed back against the proposal. [32] In September 2019, Wheeler signed a directive to prioritize efforts to reduce animal testing. Instead, the research should focus on new alternative test methods. The goal is to reduce its requests for, and funding of, mammal studies by 30% by 2025 and eliminate all ...
The glucose clamp technique was developed by University of Texas (UT) School of Medicine Professors DeFronzo, Andres and Tobin in 1979. [2] It has since been the gold standard for pharmacodynamic studies in diabetes drug development and diagnostics evaluation. [3]
Noninvasive glucose monitoring (NIGM), called Noninvasive continuous glucose monitoring when used as a CGM technique, is the measurement of blood glucose levels, required by people with diabetes to prevent both chronic and acute complications from the disease, without drawing blood, puncturing the skin, or causing pain or trauma.
Glucose testing can be used to diagnose or indicate certain medical conditions. [citation needed] High blood sugar may indicate gestational diabetes. This temporary form of diabetes appears during pregnancy, and with glucose-controlling medication or insulin symptoms can be improved. [3] type 1 and type 2 diabetes or prediabetes. If diagnosed ...
Type 3 diabetes is a proposed pathological linkage between Alzheimer's disease and certain features of type 1 and type 2 diabetes. [1] Specifically, the term refers to a set of common biochemical and metabolic features seen in the brain in Alzheimer's disease, and in other tissues in diabetes; [1] [2] it may thus be considered a "brain-specific type of diabetes."
A bioassay is an analytical method to determine the potency or effect of a substance by its effect on living animals or plants (in vivo), or on living cells or tissues (in vitro). [1] [2] A bioassay can be either quantal or quantitative, direct or indirect. [3] If the measured response is binary, the assay is quantal; if not, it is quantitative ...